In pulmonary fibrosis models, it restores superoxide dismutase (SOD) activity, reduces MDA and myeloperoxidase (MPO) levels, and decreases pro-inflammatory cytokines (TNF-α, IL-6, endothelin-1). Here, MPO is linked to pulmonary fibrosis.